ARTICLE | Clinical News
Liposomal adjuvant: Started Phase I trial
April 11, 1994 7:00 AM UTC
The Liposome Company Inc. (LIPO), Princeton, N.J. Product: Liposomal adjuvant with an influenza vaccine Indication: Prevent influenza infection Status: Wyeth-Ayerst Laboratories, a division of Ameri...